Triple 000 and Sub-penny Chart Plays

[OTCRIDER]

EHOS.0004 THC, CBD Cannabis and Medical Marijuana...

Some of the new brands we are working on are as follows:

1. With the laws shifting and markets opening up across the US for the Cannabis and Medical Marijuana industry, we have begun formulating and developing products for a planned launch into the THC and CBD market. Our development of brands and products are focused on liquid delivery in this exciting space. We are in the development of liquid Anti-Inflammation products, Anti-Nausea for cancer patients, Anti-Anxiety, Sleep and many other products leveraging the medicinal properties of Cannabis. Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and as medicine. Pharmacologically, the principal psychoactive constituent of cannabis is tetrahydrocannabinol (THC); it is one of 483 known compounds in the plant, including at least 84 other cannabinoids, such as cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabivarin (THCV), and cannabigerol (CBG). We are extremely optimistic about our potential in this fast growing market segment with products that are focused on pain, anxiety, and relief of many common ailments.

EHouse Global, Inc. 3rd Quarter Review 2014
http://www.otcmarkets.com/stock/EHOS/news